Protein family
Protein sequence
Protein function
Catalytic activity
EC number
EC number description
2.7.1.137
Transferases;
Transferring phosphorus-containing groups;
Phosphotransferases with an alcohol group as acceptor;
phosphatidylinositol 3-kinase
2.7.1.153
Transferases;
Transferring phosphorus-containing groups;
Phosphotransferases with an alcohol group as acceptor;
phosphatidylinositol-4,5-bisphosphate 3-kinase
PDB | Resolution (Å) | PDB name |
---|---|---|
5DXU | 2.64 | p110delta/p85alpha with GDC-0326 |
5M6U | 2.85 | HUMAN PI3KDELTA IN COMPLEX WITH LASW1579 |
5T8F | 2.91 | p110delta/p85alpha with taselisib (GDC-0032) |
5UBT | 2.83 | CRYSTAL STRUCTURE OF PI3K DELTA IN COMPLEX WITH A 7-(3-(PIPERAZIN-1-YL)PHENYL)PYRROLO[2,1-F][1,2,4] TRIAZIN-4-AMINE DERIVIATINE |
5VLR | 2.8 | CRYSTAL STRUCTURE OF PI3K DELTA IN COMPLEX WITH A TRIFLUORO-ETHYL-PYRAZOL-PYROLOTRIAZINE INHIBITOR |
6G6W | 2.72 | HUMAN PI3KDELTA IN COMPLEX WITH LIGAND LASW1976 |
6OCO | 2.58 | HUMAN PI3KDELTA IN COMPLEX WITH COMPOUND 6 |
6OCU | 2.77 | HUMAN PI3KDELTA IN COMPLEX WITH COMPOUND 29 |
6PYR | 2.21 | Human PI3Kdelta in complex with Compound 2-10 ((3S)-3-benzyl-3-methyl-5-[5-(2-methylpyrimidin-5-yl)pyrazolo[1,5-a]pyrimidin-3-yl]-1,3-dihydro-2H-indol-2-one) |
6PYU | 2.54 | Human PI3Kdelta in complex with Compound 4-2 ((3S)-1'-(cyclopropanecarbonyl)-5-(quinoxalin-6-yl)spiro[indole-3,2'-pyrrolidin]-2(1H)-one) |
7JIS | 2.42 | HUMAN PI3KDELTA IN COMPLEX WITH COMPOUND 2F |
7LM2 | 2.79 | HUMAN PI3KDELTA IN COMPLEX WITH COMPOUND 3C |
7LQ1 | 2.96 | HUMAN PI3KDELTA IN COMPLEX WITH COMPOUND 28 |
GO ontology | GO term | GO description |
---|---|---|
Biological Process | GO:0042113 | B cell activation |
Biological Process | GO:0035754 | B cell chemotaxis |
Biological Process | GO:0030183 | B cell differentiation |
Biological Process | GO:0050853 | B cell receptor signaling pathway |
Biological Process | GO:0042110 | T cell activation |
Biological Process | GO:0010818 | T cell chemotaxis |
Biological Process | GO:0030217 | T cell differentiation |
Biological Process | GO:0050852 | T cell receptor signaling pathway |
Biological Process | GO:0002250 | adaptive immune response |
Biological Process | GO:0016477 | cell migration |
Biological Process | GO:0006955 | immune response |
Biological Process | GO:0006954 | inflammatory response |
Biological Process | GO:0045087 | innate immune response |
Biological Process | GO:0002551 | mast cell chemotaxis |
Biological Process | GO:0043303 | mast cell degranulation |
Biological Process | GO:0060374 | mast cell differentiation |
Biological Process | GO:0030101 | natural killer cell activation |
Biological Process | GO:0035747 | natural killer cell chemotaxis |
Biological Process | GO:0001779 | natural killer cell differentiation |
Biological Process | GO:0030593 | neutrophil chemotaxis |
Biological Process | GO:0072672 | neutrophil extravasation |
Biological Process | GO:0014065 | phosphatidylinositol 3-kinase signaling |
Biological Process | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process |
Biological Process | GO:0016310 | phosphorylation |
Biological Process | GO:0045766 | positive regulation of angiogenesis |
Biological Process | GO:0030335 | positive regulation of cell migration |
Biological Process | GO:0038089 | positive regulation of cell migration by vascular endothelial growth factor signaling pathway |
Biological Process | GO:0001819 | positive regulation of cytokine production |
Biological Process | GO:0010595 | positive regulation of endothelial cell migration |
Biological Process | GO:0001938 | positive regulation of endothelial cell proliferation |
Biological Process | GO:1905278 | positive regulation of epithelial tube formation |
Biological Process | GO:0010628 | positive regulation of gene expression |
Biological Process | GO:0033031 | positive regulation of neutrophil apoptotic process |
Biological Process | GO:0051897 | positive regulation of protein kinase B signaling |
Biological Process | GO:0006468 | protein phosphorylation |
Biological Process | GO:0002679 | respiratory burst involved in defense response |
Biological Process | GO:0007165 | signal transduction |
Molecular Function | GO:0016303 | 1-phosphatidylinositol-3-kinase activity |
Molecular Function | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity |
Molecular Function | GO:0005524 | ATP binding |
Molecular Function | GO:0016301 | kinase activity |
Molecular Function | GO:0035004 | phosphatidylinositol 3-kinase activity |
Molecular Function | GO:0052812 | phosphatidylinositol-3,4-bisphosphate 5-kinase activity |
Molecular Function | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity |
Cellular Component | GO:0005737 | cytoplasm |
Cellular Component | GO:0005829 | cytosol |
Cellular Component | GO:0005942 | phosphatidylinositol 3-kinase complex |
Cellular Component | GO:0005943 | phosphatidylinositol 3-kinase complex, class IA |
Cellular Component | GO:0005886 | plasma membrane |
InterPro | InterPro name |
---|---|
IPR000341 | Phosphatidylinositol 3-kinase Ras-binding (PI3K RBD) domain |
IPR000403 | Phosphatidylinositol 3-/4-kinase, catalytic domain |
IPR001263 | Phosphoinositide 3-kinase, accessory (PIK) domain |
IPR002420 | C2 phosphatidylinositol 3-kinase-type domain |
IPR003113 | Phosphatidylinositol 3-kinase, adaptor-binding domain |
IPR011009 | Protein kinase-like domain superfamily |
IPR015433 | Phosphatidylinositol kinase |
IPR016024 | Armadillo-type fold |
IPR018936 | Phosphatidylinositol 3/4-kinase, conserved site |
IPR029071 | Ubiquitin-like domain superfamily |
IPR035892 | C2 domain superfamily |
IPR036940 | Phosphatidylinositol 3-/4-kinase, catalytic domain superfamily |
IPR037703 | PI3Kdelta, catalytic domain |
IPR042236 | Phosphoinositide 3-kinase, accessory (PIK) domain superfamily |
Pfam | Pfam name |
---|---|
PF00454 | Phosphatidylinositol 3- and 4-kinase |
PF00613 | Phosphoinositide 3-kinase family, accessory domain (PIK domain) |
PF00792 | Phosphoinositide 3-kinase C2 |
PF00794 | PI3-kinase family, ras-binding domain |
PF02192 | PI3-kinase family, p85-binding domain |
Reactome | Reactome Name | Node type | Reactome Root | Reactome Root Name |
---|---|---|---|---|
R-HSA-1257604 | PIP3 activates AKT signaling | Internal node | R-HSA-162582 | Signal Transduction |
R-HSA-1660499 | Synthesis of PIPs at the plasma membrane | Leaf | R-HSA-1430728 | Metabolism |
R-HSA-2219530 | Constitutive Signaling by Aberrant PI3K in Cancer | Leaf | R-HSA-1643685 | Disease |
R-HSA-512988 | Interleukin-3, Interleukin-5 and GM-CSF signaling | Internal node | R-HSA-168256 | Immune System |
R-HSA-6811558 | PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | Leaf | R-HSA-162582 | Signal Transduction |
R-HSA-8853659 | RET signaling | Leaf | R-HSA-1266738 | Developmental Biology |
R-HSA-9027276 | Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | Leaf | R-HSA-162582 | Signal Transduction |
R-HSA-912526 | Interleukin receptor SHC signaling | Leaf | R-HSA-168256 | Immune System |
R-HSA-912631 | Regulation of signaling by CBL | Leaf | R-HSA-168256 | Immune System |
R-HSA-983695 | Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | Leaf | R-HSA-168256 | Immune System |
Location | ECO term | Pubmed |
---|---|---|
Cytoplasm | ECO:0000269 | PubMed:22020336 |
HPO ID | HPO name |
---|---|
HP:0000006 | Autosomal dominant inheritance |
HP:0000007 | Autosomal recessive inheritance |
HP:0000010 | Recurrent urinary tract infections |
HP:0000086 | Ectopic kidney |
HP:0000122 | Unilateral renal agenesis |
HP:0000306 | Abnormality of the chin |
HP:0000316 | Hypertelorism |
HP:0000348 | High forehead |
HP:0000411 | Protruding ear |
HP:0000431 | Wide nasal bridge |
HP:0000455 | Broad nasal tip |
HP:0000463 | Anteverted nares |
HP:0000470 | Short neck |
HP:0000490 | Deeply set eye |
HP:0000609 | Optic nerve hypoplasia |
HP:0000648 | Optic atrophy |
HP:0000924 | Abnormality of the skeletal system |
HP:0000938 | Osteopenia |
HP:0000953 | Hyperpigmentation of the skin |
HP:0000998 | Hypertrichosis |
HP:0001249 | Intellectual disability |
HP:0001251 | Ataxia |
HP:0001263 | Global developmental delay |
HP:0001319 | Neonatal hypotonia |
HP:0001369 | Arthritis |
HP:0001537 | Umbilical hernia |
HP:0001744 | Splenomegaly |
HP:0001761 | Pes cavus |
HP:0001894 | Thrombocytosis |
HP:0001974 | Leukocytosis |
HP:0001999 | Abnormal facial shape |
HP:0002007 | Frontal bossing |
HP:0002014 | Diarrhea |
HP:0002020 | Gastroesophageal reflux |
HP:0002028 | Chronic diarrhea |
HP:0002037 | Inflammation of the large intestine |
HP:0002058 | Myopathic facies |
HP:0002080 | Intention tremor |
HP:0002090 | Pneumonia |
HP:0002100 | Recurrent aspiration pneumonia |
HP:0002110 | Bronchiectasis |
HP:0002119 | Ventriculomegaly |
HP:0002123 | Generalized myoclonic seizure |
HP:0002162 | Low posterior hairline |
HP:0002205 | Recurrent respiratory infections |
HP:0002403 | Positive Romberg sign |
HP:0002583 | Colitis |
HP:0002643 | Neonatal respiratory distress |
HP:0002716 | Lymphadenopathy |
HP:0002718 | Recurrent bacterial infections |
HP:0002720 | Decreased circulating IgA level |
HP:0002721 | Immunodeficiency |
HP:0002841 | Recurrent fungal infections |
HP:0002850 | Decreased circulating total IgM |
HP:0003307 | Hyperlordosis |
HP:0003460 | Decreased circulating total IgA |
HP:0003496 | Increased circulating IgM level |
HP:0003593 | Infantile onset |
HP:0003621 | Juvenile onset |
HP:0003765 | Psoriasiform dermatitis |
HP:0004313 | Decreased circulating antibody level |
HP:0004315 | Decreased circulating IgG level |
HP:0004425 | Flat forehead |
HP:0004429 | Recurrent viral infections |
HP:0005280 | Depressed nasal bridge |
HP:0005387 | Combined immunodeficiency |
HP:0005403 | T lymphocytopenia |
HP:0005407 | Decreased proportion of CD4-positive helper T cells |
HP:0005425 | Recurrent sinopulmonary infections |
HP:0005764 | Polyarticular arthritis |
HP:0006532 | Recurrent pneumonia |
HP:0006610 | Wide intermamillary distance |
HP:0007678 | Lacrimal duct stenosis |
HP:0008348 | Decreased circulating IgG2 level |
HP:0009098 | Chronic oral candidiasis |
HP:0009650 | Short distal phalanx of the thumb |
HP:0009844 | Broad middle phalanx of finger |
HP:0009891 | Underdeveloped supraorbital ridges |
HP:0010049 | Short metacarpal |
HP:0010282 | Thin lower lip vermilion |
HP:0010579 | Cone-shaped epiphysis |
HP:0010743 | Short metatarsal |
HP:0010750 | Dermatochalasis |
HP:0010976 | B lymphocytopenia |
HP:0011108 | Recurrent sinusitis |
HP:0011463 | Childhood onset |
HP:0011897 | Neutrophilia |
HP:0012178 | Reduced natural killer cell activity |
HP:0012311 | Monocytosis |
HP:0012476 | Decreased specific pneumococcal antibody level |
HP:0025540 | Abnormal T cell subset distribution |
HP:0030381 | Increased proportion of transitional B cells |
HP:0030388 | Decreased proportion of class-switched memory B cells |
HP:0031014 | Arteria lusoria |
HP:0031381 | Decreased lymphocyte proliferation in response to mitogen |
HP:0031382 | Decreased lymphocyte proliferation in response to anti-CD3 |
HP:0032132 | Decreased circulating total IgG |
HP:0032140 | Decreased specific antibody response to vaccination |
HP:0033351 | Candida esophagitis |
HP:0040022 | Clinodactyly of the 2nd finger |
HP:0040024 | Clinodactyly of the 3rd finger |
HP:0040025 | Clinodactyly of the 4th finger |
HP:0040218 | Reduced natural killer cell count |
HP:0040288 | Nasogastric tube feeding |
HP:0100540 | Palpebral edema |
HP:0100658 | Cellulitis |
HP:0100660 | Dyskinesia |
HP:0410018 | Recurrent ear infections |
Disease name | MONDO ID | ICD10 | ICD10 chapter | OMIM | Orphanet |
---|---|---|---|---|---|
combined immunodeficiency with faciooculoskeletal anomalies | MONDO:0013226 | Q87 | chapter17, Congenital malformations, deformations and chromosomal abnormalities | OMIM:613328 | Orphanet:221139 |
immunodeficiency 14 | MONDO:0014222 | D81 | chapter3, Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism | OMIM:615513 | |
immunodeficiency 14b- autosomal recessive | MONDO:0023655 | - | - | OMIM:619281 |